Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep brain stimulation of the subthalamic nucleus restores spatial reversal learning in patients with Parkinson's disease.

Brain communications·2024
Same author

α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.

Annals of neurology·2024
Same author

Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.

Molecular genetics and metabolism·2024
Same author

Turning alterations detected by mobile health technology in idiopathic REM sleep behavior disorder.

NPJ Parkinson's disease·2024
Same author

Effect of Thalamic versus Pallidal Deep Brain Stimulation on Head Tremor in Dystonic and Essential Tremor Patients-A Retrospective Video-Blinded Study.

Movement disorders clinical practice·2024
Same author

Defining Parkinson's Disease: Past and Future.

Journal of Parkinson's disease·2024

Related Experiment Video

Updated: Jul 26, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K

Characterizing Camptocormia in Parkinson's Disease Using Muscle Ultrasonography.

Rezzak Yilmaz1, Robin Wolke2, Nina Puls2

  • 1Department of Neurology, Ankara University School of Medicine, Ankara, Turkey.

Journal of Parkinson'S Disease
|June 19, 2023
PubMed
Summary

Muscle ultrasonography reliably detects changes in paraspinal muscles associated with camptocormia (CC) in Parkinson's disease (PD). This imaging technique can identify CC-related alterations in muscle thickness and echogenicity, aiding in patient management.

Keywords:
Parkinson’s diseasecamptocormiaposture

More Related Videos

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method
08:25

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

Published on: June 7, 2018

12.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Related Experiment Videos

Last Updated: Jul 26, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method
08:25

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

Published on: June 7, 2018

12.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Area of Science:

  • Neurology
  • Musculoskeletal Imaging
  • Biomedical Engineering

Background:

  • Camptocormia (CC) is a disabling spinal complication in Parkinson's disease (PD).
  • Identifying changes in lumbar paraspinal muscles (LPM) is crucial for tailoring CC treatment strategies in PD patients.

Purpose of the Study:

  • To determine if muscle ultrasonography (mUSG) can detect alterations in LPM in PD patients with CC.
  • To evaluate the reliability of mUSG for assessing LPM in this population.

Main Methods:

  • Compared LPM thickness and echogenicity (quantitative and semi-quantitative) using mUSG.
  • Assessed 17 PD patients with CC (acute and chronic), 19 PD patients without CC, and 18 healthy controls.
  • Utilized a univariate general linear model for group comparisons, with blinded raters ensuring reliability.

Main Results:

  • mUSG demonstrated substantial interrater reliability.
  • PD patients with chronic CC (PD-cCC) exhibited significantly thinner LPM compared to PD patients without CC and healthy controls.
  • Both acute and chronic CC groups showed differences in LPM echogenicity compared to non-CC groups.

Conclusions:

  • mUSG is a reliable method for assessing LPM in PD patients experiencing CC.
  • mUSG shows potential as a screening tool for detecting CC-related changes in LPM thickness and echogenicity in Parkinson's disease.